| LSTA12 (HONEDRA®)DetailsCritical limb ischemia |
Phase 3 |
| LSTA1DetailsPancreatic cancer, Cancer |
Phase 2b |
| LSTA1 + temozolomideDetailsCancer, Glioma, Glioblastoma |
Phase 2a |
| LSTA1 + Standard of careDetailsCancer, Solid tumor/s, Cholangiocarcinoma |
Phase 2a |
| LSTA1 + Durvalumab/gemcitabine/nab-paclitaxelDetailsCancer, Pancreatic cancer |
Phase 1/2 |
| LSTA1 + FOLFIRINOX (neoadjuvant) + panitumumabDetailsPancreatic cancer, Cancer, Colorectal cancer |
Phase 1/2 |
| LSTA1 + nivolumab/FOLFIRINOX,DetailsCancer, Gastroesophageal adenocarcinomas |
Phase 1/2 |
| LSTA1 + gemcitabine/nab-paclitaxelDetailsCancer, Pancreatic cancer |
Phase 1/2 |
| Gemcitabine/nab-paclitaxel + continuous infusion of certepetide/placeboDetailsPancreatic cancer, Cancer |
Phase 1/2 |
| LSTA201 (CLBS201)DetailsChronic kidney disease |
Failed |
| OLOGO (CLBS14)DetailsAngina |
Failed |
| XOWNA (CLBS16)DetailsCoronary Microvascular Dysfunction |
Failed |
| LSTA1 + temozolomideDetailsCancer, Glioblastoma, Glioma |
Phase 2a |
| LSTA1 + Durvalumab/gemcitabine/nab-paclitaxelDetailsPancreatic cancer, Cancer |
Phase 1/2 |
